AP14418c-ev
|
Abcepta, Inc.
|
BIRC2 [Centre] [RB34387], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
AP14418c
|
Abcepta, Inc.
|
BIRC2 [Centre] [RB34387], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
AP14020a-ev
|
Abcepta, Inc.
|
BIRC3 [N-term] [RB34025], Rabbit Polyclonal Antibody
|
Human
|
WB, IF, IHC-P
|
|
AP14020a
|
Abcepta, Inc.
|
BIRC3 [N-term] [RB34025], Rabbit Polyclonal Antibody
|
Human
|
WB, IF, IHC-P
|
|
AP6124a-ev
|
Abcepta, Inc.
|
cIAP2 [BIRC3] [N-term] [RB2213], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
AP6124a
|
Abcepta, Inc.
|
cIAP2 [BIRC3] [N-term] [RB2213], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
AP20326c-ev
|
Abcepta, Inc.
|
IKKB [Center Y609] [RB42186], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP20326c
|
Abcepta, Inc.
|
IKKB [Center Y609] [RB42186], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP1980c-ev
|
Abcepta, Inc.
|
NFKB1 [S932] [RB11204], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP1980c
|
Abcepta, Inc.
|
NFKB1 [S932] [RB11204], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP20829a-ev
|
Abcepta, Inc.
|
RIN1 [Y36] [RB46939], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP20829a
|
Abcepta, Inc.
|
RIN1 [Y36] [RB46939], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AM2220b-ev
|
Abcepta, Inc.
|
USP14 [N-term] [889CT6.2.1], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB
|
|
AM2220b
|
Abcepta, Inc.
|
USP14 [N-term] [889CT6.2.1], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB
|
|
AP6125a-ev
|
Abcepta, Inc.
|
XIAP [BIRC4] [N-term] [RB01793], Rabbit Polyclonal Antibody
|
Human, Mouse, Rat
|
IHC-P, WB
|
|
AP6125a
|
Abcepta, Inc.
|
XIAP [BIRC4] [N-term] [RB01793], Rabbit Polyclonal Antibody
|
Human, Mouse, Rat
|
IHC-P, WB
|
|
RI001-0125
|
Bio-Helix Co., Ltd
|
RIBOAssure RNase Inhibitor 5,000U
|
|
|
|
ATGP2333-100ug
|
NKMax Bio (ATGen)
|
TFPI [29-304 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
ATGP2333-500ug
|
NKMax Bio (ATGen)
|
TFPI [29-304 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|